Pas de connexion internet — affichage de la version enregistrée de la page.

Jasper Therapeuti…

USUSD
← Vers le Screener

Jasper Therapeutics, Inc. (US:JSPR) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
jaspertx.com
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège Social
REDWOOD CITY, United States
Actions en Circulation
33.27 M au 2026-08-10
Capitalisation Boursière
20.83 M USD
Initiés
2.87%
Investisseurs Institutionnels
39.43%
Secteur d'Activité (SIC)
Biological Products, (No Diagnostic Substances)
P/E
perte
FCF
−60.3 M USD
Dette
400 k USD
trésorerie nette
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksJSPRUSD0.5702 +1.82%actions ordinaires

Cours sur 3 Mois

US:JSPR · USD
jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Velan Capital Investment…16.04%5.34 M2026-06-30
Acorn Capital Advisors,…8.64%2.88 M2026-06-30
Kingdon Capital Manageme…8.13%2.7 M2026-06-30
Vanguard Capital Managem…7.04%2.34 M2026-06-30
Rock Springs Capital Man…6.62%2.2 M2026-06-30
Carlyle Group Inc.6.41%2.13 M2026-06-30
VANGUARD INDEX FUNDS-Van…5.01%1.67 M2026-06-30
GSA Capital Partners LLP3.21%1.07 M2026-06-30
Millennium Management Ll…2.93%973 8662026-06-30
Lion Point Capital, LP2.79%930 0002026-06-30
VANGUARD INDEX FUNDS-Van…1.88%624 0642026-06-30
Geode Capital Management…1.59%527 6162026-06-30
SHIZURU JUDITH ANNE M.D.…≈0.47%156 9012025-09-22
Fidelity Concord Street…0.38%127 5252026-07-31
MARTELL RONALD A (Chief…≈0.22%74 1182025-09-22
VANGUARD VALLEY FORGE FU…0.16%53 1962026-06-30
Fidelity Concord Street…0.15%49 8962026-07-31
Fidelity Concord Street…0.1%34 1092026-07-31
MAHAL JEETINDER SINGH (C…≈0.08%25 0092024-12-12
LUCAS SVETLANA (Director…≈0.06%20 0002025-09-22
ADVISORS' INNER CIRCLE I…0%2922026-04-30
WIGGANS THOMAS G (Direct…——2025-09-22